Annual Operating Profit:
-$2.54M+$101.17M(+97.55%)Summary
- As of today, BCRX annual operating income is -$2.54 million, with the most recent change of +$101.17 million (+97.55%) on December 31, 2024.
- During the last 3 years, BCRX annual operating profit has risen by +$175.18 million (+98.57%).
- BCRX annual operating profit is now at all-time high.
Performance
BCRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$29.79M+$8.56M(+40.32%)Summary
- As of today, BCRX quarterly operating income is $29.79 million, with the most recent change of +$8.56 million (+40.32%) on June 30, 2025.
- Over the past year, BCRX quarterly operating profit has increased by +$21.02 million (+239.98%).
- BCRX quarterly operating profit is now at all-time high.
Performance
BCRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$54.20M+$21.02M(+63.38%)Summary
- As of today, BCRX TTM operating income is $54.20 million, with the most recent change of +$21.02 million (+63.38%) on June 30, 2025.
- Over the past year, BCRX TTM operating profit has increased by +$114.52 million (+189.85%).
- BCRX TTM operating profit is now at all-time high.
Performance
BCRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BCRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +97.5% | +240.0% | +189.8% |
| 3Y3 Years | +98.6% | +185.8% | +129.9% |
| 5Y5 Years | +97.4% | +177.3% | +144.3% |
BCRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +98.6% | at high | +164.3% | at high | +135.1% |
| 5Y | 5-Year | at high | +98.6% | at high | +156.8% | at high | +129.3% |
| All-Time | All-Time | at high | +98.6% | at high | +156.8% | at high | +129.3% |
BCRX Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $29.79M(+40.3%) | $54.20M(+63.4%) |
| Mar 2025 | - | $21.23M(+570.9%) | $33.17M(+1404.4%) |
| Dec 2024 | -$2.54M(+97.5%) | -$4.51M(-158.6%) | -$2.54M(+93.8%) |
| Sep 2024 | - | $7.69M(-12.2%) | -$40.70M(+32.5%) |
| Jun 2024 | - | $8.76M(+160.5%) | -$60.32M(+32.8%) |
| Mar 2024 | - | -$14.49M(+66.0%) | -$89.78M(+13.4%) |
| Dec 2023 | -$103.71M(+30.1%) | -$42.67M(-257.9%) | -$103.71M(+3.4%) |
| Sep 2023 | - | -$11.92M(+42.4%) | -$107.35M(+4.9%) |
| Jun 2023 | - | -$20.70M(+27.1%) | -$112.87M(+11.0%) |
| Mar 2023 | - | -$28.41M(+38.6%) | -$126.89M(+14.5%) |
| Dec 2022 | -$148.44M(+16.5%) | -$46.31M(-165.5%) | -$148.44M(+3.8%) |
| Sep 2022 | - | -$17.45M(+49.8%) | -$154.30M(+15.0%) |
| Jun 2022 | - | -$34.72M(+30.5%) | -$181.44M(-2.9%) |
| Mar 2022 | - | -$49.96M(+4.3%) | -$176.30M(+0.8%) |
| Dec 2021 | -$177.72M(-1.7%) | -$52.18M(-17.0%) | -$177.72M(+0.1%) |
| Sep 2021 | - | -$44.58M(-50.7%) | -$177.95M(-1.0%) |
| Jun 2021 | - | -$29.58M(+42.4%) | -$176.23M(+4.8%) |
| Mar 2021 | - | -$51.38M(+2.0%) | -$185.16M(-6.0%) |
| Dec 2020 | -$174.76M(-75.7%) | -$52.41M(-22.3%) | -$174.76M(-42.7%) |
| Sep 2020 | - | -$42.86M(-11.3%) | -$122.46M(-6.8%) |
| Jun 2020 | - | -$38.51M(+6.0%) | -$114.69M(-3.2%) |
| Mar 2020 | - | -$40.98M(>-9900.0%) | -$111.10M(-11.7%) |
| Dec 2019 | -$99.45M(-5.6%) | -$109.00K(+99.7%) | -$99.45M(+20.2%) |
| Sep 2019 | - | -$35.10M(-0.5%) | -$124.61M(-5.6%) |
| Jun 2019 | - | -$34.92M(-19.1%) | -$118.00M(-16.4%) |
| Mar 2019 | - | -$29.33M(-16.1%) | -$101.34M(-7.6%) |
| Dec 2018 | -$94.22M(-64.1%) | -$25.26M(+11.3%) | -$94.22M(-8.5%) |
| Sep 2018 | - | -$28.49M(-56.1%) | -$86.82M(-21.1%) |
| Jun 2018 | - | -$18.25M(+17.8%) | -$71.67M(-4.0%) |
| Mar 2018 | - | -$22.21M(-24.4%) | -$68.94M(-20.1%) |
| Dec 2017 | -$57.41M(-18.1%) | -$17.86M(-33.8%) | -$57.41M(-20.3%) |
| Sep 2017 | - | -$13.35M(+14.0%) | -$47.74M(-9.4%) |
| Jun 2017 | - | -$15.52M(-45.2%) | -$43.63M(-8.4%) |
| Mar 2017 | - | -$10.69M(-30.5%) | -$40.24M(+17.2%) |
| Dec 2016 | -$48.61M(-23.2%) | -$8.19M(+11.4%) | -$48.61M(+15.6%) |
| Sep 2016 | - | -$9.24M(+23.8%) | -$57.61M(+6.4%) |
| Jun 2016 | - | -$12.13M(+36.3%) | -$61.53M(-39.7%) |
| Mar 2016 | - | -$19.05M(-10.8%) | -$44.06M(-11.7%) |
| Dec 2015 | -$39.44M(+13.8%) | -$17.19M(-30.6%) | -$39.44M(-5.4%) |
| Sep 2015 | - | -$13.16M(-346.4%) | -$37.41M(-4.3%) |
| Jun 2015 | - | $5.34M(+137.0%) | -$35.85M(+32.1%) |
| Mar 2015 | - | -$14.43M(+4.8%) | -$52.81M(-15.4%) |
| Dec 2014 | -$45.77M(-49.0%) | -$15.16M(-30.5%) | -$45.77M(-23.9%) |
| Sep 2014 | - | -$11.61M(+0.1%) | -$36.95M(-14.5%) |
| Jun 2014 | - | -$11.62M(-57.3%) | -$32.26M(+1.6%) |
| Mar 2014 | - | -$7.39M(-16.6%) | -$32.79M(-6.7%) |
| Dec 2013 | -$30.72M(+4.4%) | -$6.33M(+8.5%) | -$30.72M(+7.8%) |
| Sep 2013 | - | -$6.92M(+43.0%) | -$33.32M(+3.2%) |
| Jun 2013 | - | -$12.14M(-128.4%) | -$34.41M(-6.1%) |
| Mar 2013 | - | -$5.32M(+40.5%) | -$32.44M(-1.0%) |
| Dec 2012 | -$32.13M(+35.2%) | -$8.94M(-11.5%) | -$32.13M(+6.2%) |
| Sep 2012 | - | -$8.02M(+21.2%) | -$34.23M(+12.3%) |
| Jun 2012 | - | -$10.18M(-103.5%) | -$39.02M(+9.4%) |
| Mar 2012 | - | -$5.00M(+54.7%) | -$43.09M(+13.1%) |
| Dec 2011 | -$49.59M(-48.8%) | -$11.04M(+13.8%) | -$49.59M(-3.7%) |
| Sep 2011 | - | -$12.80M(+10.1%) | -$47.82M(-3.9%) |
| Jun 2011 | - | -$14.24M(-23.9%) | -$46.01M(-9.3%) |
| Mar 2011 | - | -$11.50M(-24.0%) | -$42.09M(-26.3%) |
| Dec 2010 | -$33.32M(-142.6%) | -$9.27M(+15.6%) | -$33.32M(-271.8%) |
| Sep 2010 | - | -$10.99M(-6.4%) | -$8.96M(-3.4%) |
| Jun 2010 | - | -$10.33M(-278.5%) | -$8.67M(-22.5%) |
| Mar 2010 | - | -$2.73M(-118.1%) | -$7.08M(+48.5%) |
| Dec 2009 | -$13.74M | $15.09M(+241.0%) | -$13.74M(+27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.70M(-22.4%) | -$19.02M(-6.3%) |
| Jun 2009 | - | -$8.74M(+6.9%) | -$17.89M(+20.6%) |
| Mar 2009 | - | -$9.39M(-195.7%) | -$22.54M(+17.0%) |
| Dec 2008 | -$27.16M(+15.8%) | $9.80M(+202.4%) | -$27.16M(+32.8%) |
| Sep 2008 | - | -$9.57M(+28.5%) | -$40.40M(+5.4%) |
| Jun 2008 | - | -$13.38M(+4.5%) | -$42.69M(-15.7%) |
| Mar 2008 | - | -$14.02M(-308.9%) | -$36.89M(-54.9%) |
| Dec 2007 | -$32.28M(+31.3%) | -$3.43M(+71.1%) | -$23.81M(+23.5%) |
| Sep 2007 | - | -$11.86M(-56.4%) | -$31.12M(+12.9%) |
| Jun 2007 | - | -$7.58M(-705.9%) | -$35.72M(+8.8%) |
| Mar 2007 | - | -$940.80K(+91.2%) | -$39.15M(+16.7%) |
| Dec 2006 | -$46.98M(-72.9%) | -$10.74M(+34.8%) | -$46.98M(-7.4%) |
| Sep 2006 | - | -$16.46M(-49.4%) | -$43.73M(-24.2%) |
| Jun 2006 | - | -$11.02M(-25.7%) | -$35.20M(-16.9%) |
| Mar 2006 | - | -$8.77M(-17.1%) | -$30.11M(-10.8%) |
| Dec 2005 | -$27.18M(-24.9%) | -$7.49M(+5.5%) | -$27.18M(-8.2%) |
| Sep 2005 | - | -$7.93M(-33.6%) | -$25.12M(-10.9%) |
| Jun 2005 | - | -$5.93M(-1.7%) | -$22.64M(-3.2%) |
| Mar 2005 | - | -$5.83M(-7.4%) | -$21.94M(-0.9%) |
| Dec 2004 | -$21.75M(-59.0%) | -$5.43M(+0.4%) | -$21.75M(-5.8%) |
| Sep 2004 | - | -$5.45M(-4.2%) | -$20.55M(-11.0%) |
| Jun 2004 | - | -$5.23M(+7.3%) | -$18.51M(-12.0%) |
| Mar 2004 | - | -$5.64M(-33.4%) | -$16.53M(-20.9%) |
| Dec 2003 | -$13.68M(+26.9%) | -$4.23M(-24.1%) | -$13.68M(+4.6%) |
| Sep 2003 | - | -$3.41M(-4.8%) | -$14.33M(+0.0%) |
| Jun 2003 | - | -$3.25M(-16.6%) | -$14.34M(+12.2%) |
| Mar 2003 | - | -$2.79M(+42.9%) | -$16.34M(+14.8%) |
| Dec 2002 | -$18.70M(-275.2%) | -$4.88M(-43.0%) | -$19.16M(-13.5%) |
| Sep 2002 | - | -$3.42M(+34.9%) | -$16.88M(-24.3%) |
| Jun 2002 | - | -$5.25M(+6.6%) | -$13.59M(-64.0%) |
| Mar 2002 | - | -$5.62M(-115.6%) | -$8.28M(-58.3%) |
| Dec 2001 | -$4.99M(+49.3%) | -$2.60M(-2088.7%) | -$5.23M(+7.9%) |
| Sep 2001 | - | -$119.00K(-316.4%) | -$5.68M(+24.7%) |
| Jun 2001 | - | $55.00K(+102.1%) | -$7.55M(+24.8%) |
| Mar 2001 | - | -$2.57M(+16.0%) | -$10.04M(-1.6%) |
| Dec 2000 | -$9.83M(-21.4%) | -$3.06M(-54.0%) | -$9.88M(-7.1%) |
| Sep 2000 | - | -$1.98M(+18.5%) | -$9.23M(+6.2%) |
| Jun 2000 | - | -$2.43M(-0.9%) | -$9.85M(-24.3%) |
| Mar 2000 | - | -$2.41M(-0.5%) | -$7.92M(+1.1%) |
| Dec 1999 | -$8.10M(-35.0%) | -$2.40M(+7.7%) | -$8.01M(-8.1%) |
| Sep 1999 | - | -$2.60M(-411.6%) | -$7.41M(-207.6%) |
| Jun 1999 | - | -$508.00K(+79.7%) | -$2.41M(+52.8%) |
| Mar 1999 | - | -$2.50M(-38.9%) | -$5.10M(+12.1%) |
| Dec 1998 | -$6.00M(+51.2%) | -$1.80M(-175.0%) | -$5.80M(+21.6%) |
| Sep 1998 | - | $2.40M(+175.0%) | -$7.40M(+41.3%) |
| Jun 1998 | - | -$3.20M(0.0%) | -$12.60M(-5.9%) |
| Mar 1998 | - | -$3.20M(+5.9%) | -$11.90M(+2.5%) |
| Dec 1997 | -$12.30M(-41.4%) | -$3.40M(-21.4%) | -$12.20M(-1.7%) |
| Sep 1997 | - | -$2.80M(-12.0%) | -$12.00M(-3.4%) |
| Jun 1997 | - | -$2.50M(+28.6%) | -$11.60M(-11.5%) |
| Mar 1997 | - | -$3.50M(-9.4%) | -$10.40M(-18.2%) |
| Dec 1996 | -$8.70M(+4.4%) | -$3.20M(-33.3%) | -$8.80M(-11.4%) |
| Sep 1996 | - | -$2.40M(-84.6%) | -$7.90M(-3.9%) |
| Jun 1996 | - | -$1.30M(+31.6%) | -$7.60M(+5.0%) |
| Mar 1996 | - | -$1.90M(+17.4%) | -$8.00M(+11.1%) |
| Dec 1995 | -$9.10M(-33.8%) | -$2.30M(-9.5%) | -$9.00M(-4.7%) |
| Sep 1995 | - | -$2.10M(-23.5%) | -$8.60M(-4.9%) |
| Jun 1995 | - | -$1.70M(+41.4%) | -$8.20M(+2.4%) |
| Mar 1995 | - | -$2.90M(-52.6%) | -$8.40M(-20.0%) |
| Dec 1994 | -$6.80M | -$1.90M(-11.8%) | -$7.00M(-37.3%) |
| Sep 1994 | - | -$1.70M(+10.5%) | -$5.10M(-50.0%) |
| Jun 1994 | - | -$1.90M(-26.7%) | -$3.40M(-126.7%) |
| Mar 1994 | - | -$1.50M | -$1.50M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of BCRX is -$2.54M
What is the all-time high annual operating profit for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual operating income is -$2.54M
What is BioCryst Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, BCRX annual operating income has changed by +$101.17M (+97.55%)
What is BioCryst Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of BCRX is $29.79M
What is the all-time high quarterly operating profit for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly operating income is $29.79M
What is BioCryst Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, BCRX quarterly operating income has changed by +$21.02M (+239.98%)
What is BioCryst Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of BCRX is $54.20M
What is the all-time high TTM operating profit for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM operating income is $54.20M
What is BioCryst Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, BCRX TTM operating income has changed by +$114.52M (+189.85%)